Reperfusion delays increase mortality riskA Quebec study has shown many myocardial infarction patients are receiving reperfusion therapy outside recommended time windows, and this is putting them at increased risk of dying within 30 days. Don’t forget fibratesA major meta-analysis of fibrate drugs has shown they modestly reduce the risk of major cardiovascular events, mainly through prevention of coronary artery disease and the need for revascularization. 2010 Canadian hypertension guidelines now available Warfarin patients often outside therapeutic range Consider panic in unexplained chest pain cases Smoking cancels benefit of alcohol on stroke risk Pneumococcal vaccine doesn’t reduce cardiac risk Stenting staves off amputation in critical limb ischemia Drug-eluting devices offer a new option for patients ineligible for vascular surgery Vitamin D deficiency not linked to myalgia in statin patients More patients reach LDL goals with rosuvastatin combo First Previous 75 76 77 78 79 Next Last
